Form 4: Leap Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Thomas John Dietz, a Director of Leap Therapeutics, Inc., sold 20,000 shares of common stock on August 26, 2026 for $1.72 per share.
Summary
- Open-market sale: disposed of 20,000 Common Stock at $1.72 ($34,400) on August 26, 2026; holds 132,500 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $34,400 of stock on the open market.
Insider Transactions
Thomas John Dietz — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Open-market sale | Common Stock | 20,000 | $2 | $34.4K | 132,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Open-market sale (20,000 shares) |
Keywords
insider transaction, Form 4, CYPH, CYPHERPUNK TECHNOLOGIES INC., bearish, Thomas John Dietz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.